BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
| 07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -61.27% | 21.77% | 79.89% | 34.55% | 52.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -61.27% | 21.77% | 79.89% | 34.55% | 52.65% |
| Operating Income | 61.27% | -21.77% | -79.89% | -34.55% | -52.65% |
| Income Before Tax | -16.44% | -305.95% | -241.46% | -299.15% | 64.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.44% | -305.95% | -241.46% | -299.15% | 64.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.44% | -305.95% | -241.46% | -299.15% | 64.66% |
| EBIT | 61.27% | -21.77% | -79.89% | -34.55% | -52.65% |
| EBITDA | 51.64% | 988.70% | -282.57% | 6.37% | -23.28% |
| EPS Basic | 20.00% | -153.33% | -213.79% | -254.55% | 68.75% |
| Normalized Basic EPS | 62.96% | -140.00% | -200.00% | -386.67% | 32.50% |
| EPS Diluted | 20.00% | -153.33% | -213.79% | -254.55% | 68.75% |
| Normalized Diluted EPS | 62.96% | -140.00% | -200.00% | -386.67% | 32.50% |
| Average Basic Shares Outstanding | 50.63% | 65.78% | 7.57% | 11.71% | 12.72% |
| Average Diluted Shares Outstanding | 50.63% | 65.78% | 7.57% | 11.71% | 12.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
